Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ASRT

Assertio Therapeutics

$0.75

-0.0707 (-8.60%)

16:55
11/06/19
11/06
16:55
11/06/19
16:55
Earnings
Breaking Earnings news story on Assertio Therapeutics »

Assertio Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

ASRT

Assertio Therapeutics

$0.75

-0.0707 (-8.60%)

16:54
11/06/19
11/06
16:54
11/06/19
16:54
Earnings
Assertio Therapeutics reports Q3 EPS 24c, consensus 24c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

Tuesday
CVET

Covetrus

$10.47

0.36 (3.56%)

, ASRT

Assertio Therapeutics

$0.80

-0.0335 (-4.01%)

04:55
11/05/19
11/05
04:55
11/05/19
04:55
Hot Stocks
Covetrus to replace Assertio Therapeutics in S&P 600 at open on 11/5 »

Assertio Therapeutics is…

CVET

Covetrus

$10.47

0.36 (3.56%)

ASRT

Assertio Therapeutics

$0.80

-0.0335 (-4.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Nov

Over a week ago
CVET

Covetrus

$9.29

0.46 (5.21%)

, ASRT

Assertio Therapeutics

$1.02

0.0227 (2.28%)

17:35
10/30/19
10/30
17:35
10/30/19
17:35
Hot Stocks
Covetrus to replace Assertio Therapeutics in S&P 600 at open on 11/5 »

Assertio Therapeutics is…

CVET

Covetrus

$9.29

0.46 (5.21%)

ASRT

Assertio Therapeutics

$1.02

0.0227 (2.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Nov

ASRT

Assertio Therapeutics

$1.18

-0.065 (-5.24%)

09:10
10/21/19
10/21
09:10
10/21/19
09:10
Hot Stocks
Assertio Therapeutics says West receives CRL from FDA on cosyntropin NDA »

Assertio Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
ASRT

Assertio Therapeutics

$2.67

-0.1 (-3.61%)

16:27
08/07/19
08/07
16:27
08/07/19
16:27
Earnings
Assertio Therapeutics backs FY 19 adj. EBITDA view $118M-128M »

The Company is confirming…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Sep

ASRT

Assertio Therapeutics

$2.67

-0.1 (-3.61%)

16:25
08/07/19
08/07
16:25
08/07/19
16:25
Earnings
Assertio Therapeutics reports Q2 EPS (21c), consensus 24c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

  • 09

    Sep

ASRT

Assertio Therapeutics

$3.17

(0.00%)

04:55
06/13/19
06/13
04:55
06/13/19
04:55
Conference/Events
Assertio Therapeutics management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

ASRT

Assertio Therapeutics

$3.17

0.095 (3.09%)

04:55
06/12/19
06/12
04:55
06/12/19
04:55
Conference/Events
Assertio Therapeutics management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

  • 13

    Jun

ASRT

Assertio Therapeutics

$2.99

-0.005 (-0.17%)

07:57
06/07/19
06/07
07:57
06/07/19
07:57
Conference/Events
Assertio Therapeutics management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

  • 13

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.